<code id='9E602A3FBF'></code><style id='9E602A3FBF'></style>
    • <acronym id='9E602A3FBF'></acronym>
      <center id='9E602A3FBF'><center id='9E602A3FBF'><tfoot id='9E602A3FBF'></tfoot></center><abbr id='9E602A3FBF'><dir id='9E602A3FBF'><tfoot id='9E602A3FBF'></tfoot><noframes id='9E602A3FBF'>

    • <optgroup id='9E602A3FBF'><strike id='9E602A3FBF'><sup id='9E602A3FBF'></sup></strike><code id='9E602A3FBF'></code></optgroup>
        1. <b id='9E602A3FBF'><label id='9E602A3FBF'><select id='9E602A3FBF'><dt id='9E602A3FBF'><span id='9E602A3FBF'></span></dt></select></label></b><u id='9E602A3FBF'></u>
          <i id='9E602A3FBF'><strike id='9E602A3FBF'><tt id='9E602A3FBF'><pre id='9E602A3FBF'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:92
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Readout LOUD Podcast: Legal insider trading, booming biotech stocks
          Readout LOUD Podcast: Legal insider trading, booming biotech stocks

          Arebiotech’sdogdaysover?What’saPIPE?AndwhatcanunseatWegovy?Wecoverallthatandmorethisweekon“TheReadou

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Cholera vaccine supply gets boost as demand surges globally

          AnurseshowsacholeravaccineinGedaref,Sudan,duringavaccinationcampaign.Anewvaccine,calledEuvichol-S,wi